{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:40:39Z","timestamp":1772556039629,"version":"3.50.1"},"reference-count":26,"publisher":"BMJ","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.l1733","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T14:55:34Z","timestamp":1557327334000},"page":"l1733","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Preventing medication-related osteonecrosis of the jaw"],"prefix":"10.1136","author":[{"given":"Lara","family":"Zebic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"key20190509000323_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"key20190509000323_ref2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.2015.680"},{"key":"key20190509000323_ref3","unstructured":"Scottish Dental Clinical Effectiveness Programme. Oral health management of patients at risk of medication-related osteonecrosis of the jaw: dental clinical guidance. 2017. http:\/\/www.sdcep.org.uk\/wp-content\/uploads\/2017\/04\/SDCEP-Oral-Health-Management-of-Patients-at-Risk-of-MRONJ-Guidance-full.pdf."},{"key":"key20190509000323_ref4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.2017.1039"},{"key":"key20190509000323_ref5","unstructured":"Medicines and Healthcare products Regulatory Agency. Bevacizumab and sunitinib: risk of osteonecrosis of the jaw. Drug Safety Update. 2014. https:\/\/www.gov.uk\/drug-safety-update\/bevacizumab-and-sunitinib-risk-of-osteonecrosis-of-the-jaw."},{"key":"key20190509000323_ref6","unstructured":"Medicines and Healthcare products Regulatory Agency. Aflibercept (Zaltrap): minimising the risk of osteonecrosis of the jaw. Drug Safety Update. 2016. https:\/\/www.gov.uk\/drug-safety-update\/aflibercept-zaltrap-minimising-the-risk-of-osteonecrosis-of-the-jaw."},{"key":"key20190509000323_ref7","unstructured":"Medicines and Healthcare products Regulatory Agency. Denosumab updated: recommendations: Minimising the risk of osteonecrosis of the jaw. Drug Safety Update. 2014. https:\/\/www.gov.uk\/drug-safety-update\/denosumab-updated-recommendations#osteonecrosis-of-the-jaw."},{"key":"key20190509000323_ref8","unstructured":"Medicines and Healthcare products Regulatory Agency. Bisphosphonates: use and safety. Guidance. 2014. https:\/\/www.gov.uk\/government\/publications\/bisphosphonates-use-and-safety\/bisphosphonates-use-and-safety."},{"key":"key20190509000323_ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2231-0762.178742"},{"key":"key20190509000323_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"key20190509000323_ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607948"},{"key":"key20190509000323_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60908-4"},{"key":"key20190509000323_ref13","unstructured":"National Institute for Health and Care Excellence. Early and locally advanced breast cancer: diagnosis and treatment (clinical guideline CG80). 2017. https:\/\/www.nice.org.uk\/guidance\/CG80."},{"key":"key20190509000323_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.11.012"},{"key":"key20190509000323_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2693"},{"key":"key20190509000323_ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2405"},{"key":"key20190509000323_ref17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr435"},{"key":"key20190509000323_ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-0866-3"},{"key":"key20190509000323_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2013.10.002"},{"key":"key20190509000323_ref20","unstructured":"Faculty of General Dental Practice (UK). National study on avascular necrosis of the jaws including bisphosphonate-related necrosis. 2012. https:\/\/www.fgdp.org.uk\/sites\/fgdp.org.uk\/files\/docs\/in-practice\/amps-online\/final%20report-27.11.12.pdf."},{"key":"key20190509000323_ref21","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2010.0082"},{"key":"key20190509000323_ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1479"},{"key":"key20190509000323_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.03.050"},{"key":"key20190509000323_ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.12455"},{"key":"key20190509000323_ref25","first-page":"CD012432","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"10","author":"Beth-Tasdogan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key20190509000323_ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-013-0561-6"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.l1733","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.l1733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:01:59Z","timestamp":1601082119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.l1733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":26,"alternative-id":["10.1136\/bmj.l1733"],"URL":"https:\/\/doi.org\/10.1136\/bmj.l1733","relation":{},"ISSN":["0959-8138","1756-1833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]}}}